Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BLND
BLND logo

BLND Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Blend Labs Inc (BLND) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.700
1 Day change
1.80%
52 Week Range
4.490
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Blend Labs Inc (BLND) is not a strong buy for a beginner, long-term investor at this time. The stock has shown weak financial performance, declining revenue, and mixed analyst sentiment. While the technical indicators are neutral and options data suggests low bearish sentiment, the lack of positive catalysts and disappointing Q1 guidance make this stock a hold rather than a buy.

Technical Analysis

The MACD is above 0 but contracting, RSI is neutral at 55.201, and moving averages are converging, indicating no strong trend. The stock is trading close to its pivot level of 1.63, with resistance at 1.779 and support at 1.481.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
7

Positive Catalysts

  • Analysts expect long-term growth as mortgage volumes recover.

Neutral/Negative Catalysts

  • Analysts have lowered price targets due to disappointing Q1 guidance and pressure from elevated interest rates. No recent news or significant insider/hedge fund activity.

Financial Performance

In Q4 2025, revenue declined by 21.83% YoY to $32.37M. Net income improved slightly but remained negative at -$7.28M. EPS was flat at -0.03 YoY, and gross margin increased marginally to 75.38%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets recently, with ratings ranging from Neutral to Outperform. The average price target has been reduced, reflecting concerns over near-term challenges.

Wall Street analysts forecast BLND stock price to rise
5 Analyst Rating
Wall Street analysts forecast BLND stock price to rise
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 1.700
sliders
Low
3
Averages
4.19
High
5.25
Current: 1.700
sliders
Low
3
Averages
4.19
High
5.25
Keefe Bruyette
Market Perform
downgrade
AI Analysis
2026-03-12
Reason
Keefe Bruyette
Price Target
AI Analysis
2026-03-12
downgrade
Market Perform
Reason
Keefe Bruyette lowered the firm's price target on Blend Labs to $2.25 from $3.50 and keeps a Market Perform rating on the shares.
UBS
Karl Keirstead
Neutral
downgrade
$3 -> $2
2026-03-11
Reason
UBS
Karl Keirstead
Price Target
$3 -> $2
2026-03-11
downgrade
Neutral
Reason
UBS analyst Karl Keirstead lowered the firm's price target on Blend Labs to $2 from $3 and keeps a Neutral rating on the shares. The firm says elevated interest rates are pressuring the company's forward estimates.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BLND
Unlock Now

People Also Watch